Which GLP-1 Medication Is Right for You? A Decision Framework
FAQ-000116
Direct Answer
There is no single "best" GLP-1 medication, the right choice genuinely depends on your specific health goals, approved indication (diabetes versus weight management), dosing frequency preference, and individual tolerance for side effects. This is a real, factual comparison to help you understand your options, not a substitute for a direct conversation with your provider about what's right for your specific situation.
Full Comparison
| Generic Name | Brand Name(s) | Mechanism | Dosing Frequency | Avg. Weight Loss (trials) |
|---|---|---|---|---|
| Semaglutide | Ozempic, Wegovy | Single (GLP-1) | Weekly | ~15% |
| Tirzepatide | Mounjaro, Zepbound | Dual (GLP-1/GIP) | Weekly | ~20% |
| Liraglutide | Victoza, Saxenda | Single (GLP-1) | Daily | ~8% |
| Dulaglutide | Trulicity | Single (GLP-1) | Weekly | ~4-6% (diabetes-focused) |
| Exenatide | Byetta, Bydureon BCise | Single (GLP-1) | Twice daily / Weekly | Modest, diabetes-focused |
| Lixisenatide | Adlyxin | Single (GLP-1) | Daily | Modest, diabetes-focused |
| Retatrutide (investigational) | Not yet approved | Triple (GLP-1/GIP/glucagon) | Weekly | ~28-30% (trial data) |
How to Think About This Practically
If dosing frequency matters most to you, weekly options (semaglutide, tirzepatide, dulaglutide) mean far less day-to-day treatment burden than daily options. If maximum average weight loss is the priority, tirzepatide currently leads among approved medications, based on published trial data. If you're managing type 2 diabetes specifically, rather than weight management, dulaglutide, exenatide, and lixisenatide have real, established track records specifically in that context.
Why "Best" Really Means "Right for You"
Effectiveness data reflects group averages, individual response varies meaningfully. A medication with a lower average result might work better for your specific body and tolerance than one with a higher average, this is exactly why working directly with a provider who can adjust based on your actual, real response matters more than picking the "top" medication on a chart.
Bottom Line
Use this comparison to understand your real options and ask informed questions, not to self-select a medication without medical guidance. Your provider can help translate these general trial averages into a decision that fits your specific health profile.
References
- FDA Prescribing Information for all listed medications
- Published Phase 3 trial data (SURMOUNT, STEP, SURPASS, SURMOUNT-5)
Related Resources
- Semaglutide vs. Tirzepatide
- The Three Generations of GLP-1 Medications: Single, Dual, and Triple Agonists
- Which GLP-1 Medication Has the Fewest Side Effects?
Explore More
Explore the full GLP-1 Tracker knowledge base on DietApp.com
Get Started
Explore the GLP-1 Tracker knowledge base for accurate, sourced information on every GLP-1 medication.
About DietApp.com
DietApp.com combines evidence-based GLP-1 medication education with practical treatment tracking tools. This article is for general informational purposes and is not medical advice.
which-glp-1-medication-is-right-for-you